Literature DB >> 2556222

Effect of ingestion of hemoproteins on fecal excretion of hemes and porphyrins.

I S Rose1, G P Young, D J St John, M C Deacon, D Blake, R W Henderson.   

Abstract

Stools from asymptomatic volunteers on diets containing red meat, whole blood, or high fiber were analyzed for their content of hemes and dicarboxylic (heme-derived) porphyrins by the "HemoQuant" assay, the "Hemoccult" test, and "high-performance" liquid chromatography (HPLC). In 49 subjects, ingestion of red meat increased HemoQuant-determined combined fecal heme plus dicarboxylic porphyrins by an average 375%; the contribution of heme-derived porphyrins to total fecal porphyrins increased from 37% to 78%. Of subjects on a red-meat diet, 27% passed stools with a porphyrin content suggestive of a porphyria, compared with only 4% on a red-meat-free diet. These increases were due largely to protoporphyrin and its derivatives pemptoporphyrin and deuteroporphyrin, all of which were present in feces as iron-free porphyrins and iron-ligated (heme) forms. Ingestion of blood had an effect similar to that of red meat, but ingestion of fiber had no effect. These effects of dietary and endogenous hemoproteins must be considered when such methods are used to test feces for occult blood or to test for excess fecal porphyrins as an indicator of a porphyria.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556222

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  10 in total

1.  Quantitative measurement of faecal blood loss: comparison of radioisotopic and chemical analyses.

Authors:  M B Leahy; M J Pippard; M B Salzmann; M G Rinsler; R Hesp; T Smith
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

2.  Effects of high-fiber diet on fecal blood content (HemoQuant assay) in healthy subjects.

Authors:  J L Slavin; E A Melcher; M Sundeen; S Schwartz
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 3.  Dietary interventions for fecal occult blood test screening: systematic review of the literature.

Authors:  Gerald Konrad
Journal:  Can Fam Physician       Date:  2010-03       Impact factor: 3.275

Review 4.  Are medication restrictions before FOBT necessary?: practical advice based on a systematic review of the literature.

Authors:  Gerald Konrad; Alan Katz
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

5.  Study of protoporphyrin IX elimination by body excreta: a new noninvasive cancer diagnostic method?

Authors:  Flávia R O Silva; Camila T Nabeshima; Maria H Bellini; Nestor Schor; Nilson D Vieira; Lilia C Courrol
Journal:  J Fluoresc       Date:  2012-09-09       Impact factor: 2.217

6.  New Plausible Mechanism for Gastric and Colorectal Carcinogenesis: Free Radical-Mediated Acetaldehyde Generation in a Heme/Myoglobin-Linoleate-Ethanol Mixture.

Authors:  Hiroshi Kasai; Kazuaki Kawai
Journal:  ACS Omega       Date:  2021-04-28

Review 7.  Advances in Fecal Occult Blood Tests: the FIT revolution.

Authors:  Graeme P Young; Erin L Symonds; James E Allison; Stephen R Cole; Callum G Fraser; Stephen P Halloran; Ernst J Kuipers; Helen E Seaman
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

8.  Usefulness of fecal immunochemical test and fecal calprotectin for detection of active ulcerative colitis.

Authors:  Dong Ju Kim; Yoon Mi Jeoun; Dong-Won Lee; Ja Seol Koo; Sang Woo Lee
Journal:  Intest Res       Date:  2018-10-10

9.  Bacteroides fragilis requires the ferrous-iron transporter FeoAB and the CobN-like proteins BtuS1 and BtuS2 for assimilation of iron released from heme.

Authors:  Edson R Rocha; Hector A Bergonia; Svetlana Gerdes; Charles Jeffrey Smith
Journal:  Microbiologyopen       Date:  2018-06-21       Impact factor: 3.139

10.  Evaluation of the guaiac fecal occult blood test for detection of gastrointestinal bleeding in the rhesus macaque (Macaca mulatta).

Authors:  Rachel Elizabeth Cooper; Eric Kenneth Hutchinson; Jessica Marie Izzi
Journal:  J Med Primatol       Date:  2019-11-01       Impact factor: 0.667

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.